Ctrl Tx
1 known investors
cTRL is a biotech company developing cell-based immunotherapies for cancer, drawing on expertise in the adaptive immune system, immuno-oncology, biomedical engineering, and cell therapy research and development.
Investors · 1
Frequently asked questions
- What does Ctrl Tx do?
- cTRL is a biotech company developing cell-based immunotherapies for cancer, drawing on expertise in the adaptive immune system, immuno-oncology, biomedical engineering, and cell therapy research and development.
- Who are Ctrl Tx's investors?
- Ctrl Tx's investors include Portal Innovations.